Clinical Trials Browser

Phase 1/2 × Neoplasms, Plasma Cell × Immunologic Techniques × Clear all

NCT00478075 2011-05-11

Samarium Sm 153 Lexidronam Pentasodium and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell